Article Type
Original Research
152 articles in Psychopharmacology Bulletin
Association of CBC-Derived Indices of Inflammation with Response to Glecaprevir/Pibrentasvir for PTSD
GH001 Efficacy is Independent of Prior Antidepressant Treatment Failures in Treatment-Resistant Depression: A Post Hoc Analysis of a Phase 2b Randomized Controlled Trial
Michael E Thase, Brian Brennan, Rachael MacIsaac, Luca Pani, Velichka Valcheva, Wiesław J Cubała
Efficacy and Safety of Asenapine in Bipolar Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Muneeb Ahmad Muneer, Hafsa, Umair Ahmed, Abdullah Mahmood, Moneeba Khalid, Zain Ali, Warda Fatima Shafee, Suboor Ali Khan, Hanana Nasir, Muhammad Khubair Farrukh, Ume Khansa, Hafsa Arshad Azam Raja, Syed Tehseen Haider
Academic Stress in Dental Students Analysis: Questionnaire Design and Validation Study
Abdul Gani Soulissa, Indrayadi Gunardi, Tri Erri Astoeti, Mita Juliawati, Komariah, Lia Hapsari Andayani
Suzetrigine for Pain Management: An Observational Study of Early Adoption Patterns
Jamal Hasoon, Ivan Urits, Omar Viswanath, Farnad Imani, Alaa Abd-Elsayed
Smoking Status Among Patients Presenting to a Chronic Pain Clinic: A Retrospective Review from a University-Affiliated Pain Clinic
Jamal Hasoon, Jacob Ng, John Spikes, Karla Samaniego, Omar Viswanath, Ivan Urits, Christopher L Robinson
A Retrospective Study of Mood and Anxiety Disorders Management Profile (MooD-MaP) of Patients Admitted at the Makati Medical Center from 2014–2017
Carmina Charmaine G Bernardo, Elaine Angela O Leynes, Sophia Grace Benosa, Lorraine Freyja Linsangan, Robin Myan Dantes, Vichka Claire Sison, Ormalyn Bayting
Clavulanic Acid Attenuated Cocaine Craving in Individuals with Cocaine Use Disorder
Mary F Morrison, Ronan Cunningham, M Ingre Walters, Daohai Yu, Xiaoning Lu, Joya Maser, Kyle M Kampman
Body Dysmorphic Disorder Among Young Individuals: Prevalence and Psychological Correlates
Aastha Shah, Rahul Gandhi, Aesha Variya, Apurva Vaishnav, Archana Navale
Incidence and Risk Factors of Clozapine-Induced Neutropenia among Patients with Schizophrenia in Taif, Saudi Arabia
Personalizing Treatment for Acute Alcoholic Hallucinosis: Clinical Utility of Integrated Pharmacogenetic Testing, Metabolic Phenotyping, and microRNA Biomarkers
Valentin Skryabin, Anton Masyakin, Sergei Pozdniakov, Igor Shatokhin, Svetlana Sokolova, Valentina Ivanchenko, Polina Makartseva
Risk of Obesity in Patients Treated with Clozapine or Olanzapine: A Simple, Clinically Useful Prediction Tool
Tramadol Utilization Patterns: A One-Year Retrospective Review
Glecaprevir/Pibrentasvir for Post Traumatic Stress Disorder
Bradley V. Watts, Jessica E. Hoyt, Krista D. Disano, Crystal M. Noller, Luke Rozema, Danielle M. Foster, Matthew Vincenti, Brian Shiner
Trends in Opioid Prescribing and Co-Prescription of Opioid Antagonists: A Retrospective Analysis over a 12-Month Period
Jamal Hasoon, Ahmed Abdalla, Giuliano Lo Bianco, Christopher L. Robinson
Differences in the Prevalence of Use and Dosage of Psychotropic Drugs by Smoking Status in Inpatient and Outpatient: An Observational, Analytical, Cross-Sectional Study
Pedro Damian Gargoloff, Martín A. Urtasun, Raul Riveros, Iván Omar Moreno Frade, Martín Cañás
A Prospective 12-week Randomized Controlled Trial of Remotely-Delivered Customized Adherence Enhancement for Poorly Adherent Individuals with Schizophrenia vs Enhanced Treatment as Usual
Martha Sajatovic, Jennifer B. Levin, Gracie Howard-Griggs, Jessica Surdam, Jacqueline Krehel-Montgomery, Sakshi Priya, Nicole Fiorelli, Farren Briggs
Antiepileptic Drugs and Bone Health: Current Concepts
Antonio Siniscalchi, Sean Murphy, Erika Cione, Leonardo Piro, Giovambattista De Sarro, Luca Gallelli
Autism Spectrum Disorder Screening at 18–36 Months in Infants with Moderate and Severe Neonatal Encephalopathy: Is Routine Screening Required?
Impact of Recent Methamphetamine Use on Vancomycin Clearance
Assesment of Risk Factors for Tardive Dyskinesia
Melek Kanarya Vardar, Mehmet Emin Ceylan, Bariş Önen Ünsalver
Impact of Gabapentin Adjunct use with Benzodiazepines for the Treatment of Alcohol Withdrawal in a Psychiatric Hospital
Nina Vadiei, Tawny L. Smith, Amy E. Walton, Kimberly L. Kjome
Administration of Sub-anesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients with Treatment Resistant Depression: A Double Blind Placebo Controlled Trial
Identifying Predictors of Primary Adherence to Second Generation Long-Acting Injectable Antipsychotics Following Discharge from an Acute Inpatient Psychiatry Unit
Jenna L. Gilbert, Leigh Anne Nelson, Carrie R. Kriz, Yifei Liu, Courtney A. Iuppa, Lauren A. Diefenderfer, Ellie S.R. Elliott, Roger W. Sommi
Oral Antipsychotic Versus Long- Acting Injections Antipsychotic in Schizophrenia Spectrum Disorder: a Mirror Analysis in a Real-World Clinical Setting
Nicola Poloni, Marta Ielmini, Ivano Caselli, Giulia Lucca, Alessandra Gasparini, Alessandra Gasparini, Giorgia Lorenzoli, Camilla Callegari
Asenapine in the Treatment of Bipolar Depression
Rif S. El-Mallakh, Sharon Nuss, Dong Gao, Yonglin Gao, Surriya Colleen Ahmad, Clare Schrodt, Caleb Adler
Sequential Multiple Assignment Randomized Treatment (SMART) for Bipolar Disorder at Any Phase of Illness and at least Mild Symptom Severity
Keming Gao, Jodi G. Arnold, Thomas J. Prihoda, Marlon Quinones, Vivek Singh, Martha Schinagle, Carla Conroy, Nicole D’Arcangelo, Yuanhan Bai, Joseph R. Calabrese, Charles L. Bowden
Demographic Variation in the Use of Prazosin for Treatment of Sleep Disturbance in Combat Veterans with PTSD
Miriam L. Rubin, Laurel A. Copeland, Aimee R. Kroll-Desrosiers, Alice G. Knittel
Major Depression Comorbid with Medical Conditions: Analysis of Quality of Life, Functioning, and Depressive Symptom Severity
Waguih William IsHak, Alexander J. Steiner, Anna Klimowicz, Kaitlyn Kauzor, Jonathan Dang, Brigitte Vanle, Christina Elzahaby, Mark Reid, Lekeisha Sumner, Itai Danovitch
Characterizing the Effects of Quetiapine in Military Post-Traumatic Stress Disorder
Gerardo Villarreal, Mark B. Hamner, Clifford Qualls, José M. Cañive
Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?
Thomas J. Maestri, Lisa M. Mican, Heather Rozea, Jamie C. Barner
Three-Year Naturalistic Study On Early Use Of Long-Acting Injectable Antipsychotics In First Episode Psychosis
Sofia Medrano, Amal Abdel-Baki, Emmanuel Stip, Stéphane Potvin
Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial
Willie R. Earley, Hua Guo, György Németh, Judit Harsányi, Michael E. Thase
Prescribing Patterns of Gabapentinoids in Chronic Pain Management: A Single Institution Retrospective Chart Review
Richard T Tran, Anand S Patil, Parker P Nguyen, Grace H Nguyen, Amad Qadeer, Grant H Chen, Ranganathan Govindaraj, Jamal Hasoon
Use of a Personalized Clinical Decision Support System for Dosing in Psychopharmacotherapy in Patients with Alcoholic Hallucinosis Based on Pharmacogenomic Markers
VYu Skryabin, AE Petukhov, SA Pozdniakov, VA Ivanchenko, IA Zaytsev, SS Miroshkin, SI Sokolova, IV Bure, VV Smirnov, DA Sychev
Assessment of the Correlation Between Unipolar and Bipolar Depression, Calcium Levels, Thyroid Function, and Inflammatory Markers: A Pilot Cross-Sectional Study
Marta Ielmini, Daniela Gallo, Maria Laura Tanda, Eliana Piantanida, Camilla Callegari, Ivano Caselli
Trends in Outpatient Buprenorphine Prescribing for Chronic Pain: A Retrospective Analysis Over 18 Months
Jamal Hasoon, Ahish Chitneni, Omar Viswanath, Ivan Urits, Farnad Imani, Giustino Varrassi
Kuwait-Mental Illness Disability Scale (K-MIDS): A Proposal
OPRM1 rs1799971 Polymorphism Predicts Differential Response to Extended-Release Naltrexone in Alcohol Use Disorder: The Interplay of Genetics and Motivation
Valentin Skryabin, Sergei Miroshkin, Anton Masyakin, Sergei Pozdniakov, Valentina Ivanchenko, Valery Shipitsin
Comparison of Stress, Anxiety and Depression in Preclinical and Clinical Dental Students
Yohana Yusra, Indrayadi Gunardi, Wiwiek Poedjiastoeti, Anggraeny Putri Sekar Palupi, Ade Prijanti Dwisaptarini, Jamison Wijaya, Elizabeth Fitriana Sari
Methadone Prescribing Patterns at a Single Institution: A Retrospective Study and Clinical Implications
Jamal Hasoon, Amad Qadeer, Grant H Chen, Omar Viswanath, Ivan Urits, Christopher L Robinson
Prevalence of THC-Positive Urine Drug Screens in Patients Receiving Chronic Opioid Therapy: A Retrospective Review
Jamal Hasoon, Omar Viswanath, Ivan Urits, Alaa Abd-Elsayed, Alan D Kaye
Effects of Valproate on Intracellular Calcium Ion Signaling: Implications for Mechanistic Research
Pilot Trial of SDX/d-MPH Adult ADHD Examining Effects Throughout the Day
Lenard A Adler, Dayeon Cho, Terry Leon, Mariane Guschwan, Caleb A Massimi, Deepti Anbarasan
Macrophage Migration Inhibitory Factor and Interleukin 1-β mRNA Levels as Predictors of Antidepressant Treatment Response in Major Depression
Henry R Kranzler, Annjanette Stone, Steven A Schichman, L Michelle Griffin, Hannah Roggenkamp, Michael E Thase, Kevin G Lynch, David W Oslin
Treatment of Parental Depression and Reduced Risk in Offspring-Does It Have Anything to Do with Offspring Gender?
Are Standardized Tests Sensitive to Early Cognitive Change in Parkinson’s Disease?
Travis H Turner, Daniel H Lench, Robin Adams, Sandra Wilson, Christina Marsicano, Federico Rodriguez-Porcel
Association Between Symptom Severity and Medication Adherence in Adolescents with Bipolar Disorder Demonstrating Suboptimal Adherence
Martha Sajatovic, Jennifer B Levin, Avani Modi, Molly McVoy, Larry F Forthun, Raechel Cooley, Jessica Black, Carla Conroy, Kaylee Sarna, Farren B Briggs, Melissa DelBello
Effects of Venlafaxine on the Size of Brain and Expression of SHANK3, TUBB5 and DDC Genes in BALB/c Mice
Relationship of CYP3A4*1B Single Nucleotide Polymorphism to the Efficiency and Safety Profiles of Haloperidol in Patients Enduring Acute Alcoholic Hallucinosis
AA Parkhomenko, MS Zastrozhin, VYu Skryabin, AE Petukhov, SA Pozdniakov, VA Ivanchenko, IA Zaytsev, IV Bure, PO Bochkov, KA Akmalova, VV Smirnov, EA Bryun, DA Sychev
Relationship of the 1846G > A Polymorphism of the CYP2D6 Gene to the Equilibrium Concentration Levels of Haloperidol in Patients with Acute Alcoholic Hallucinosis
AA Parkhomenko, MS Zastrozhin, VYu Skryabin, AE Petukhov, SA Pozdniakov, VA Ivanchenko, IA Zaytsev, IV Bure, PO Bochkov, KA Akmalova, VV Smirnov, EA Bryun, DA Sychev
Association of Psychopharmacological Medication Preference with Autistic Traits and Emotion Regulation in ADHD
Burcu Ozbaran, Ipek Inal-Kaleli, Nurhak Dogan, Halil Ibrahim Colak, Anil Altunkaya, Beyza Ozbaran, Sezen Kose
A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide
A Pilot Study to Explore the Effect of Long Acting Injectable Antipsychotics on Aggression
Tiffany M Hopkins, O. Greg Deardorff, Yifei Liu, Megan G Trout, Roger W Sommi, Niels C Beck
Clavulanic Acid Decreases Cocaine Cue Reactivity in Addiction-Related Brain Areas, a Randomized fMRI Pilot Study
Linda S Callans, Helene Philogene-Khalid, Kanchana Jagannathan, Ronan Cunningham, Daohai Yu, Xiaoning Lu, M. Ingre Walters, Mary F Morrison
Efficacy of Rivastigmine Augmentation on Positive and Negative Symptoms, General Psychopathology, and Quality of Life in Patients with Chronic Schizophrenia: A Randomized Controlled Trial
Sepideh Herizchi, Ali Reza Shafiee-Kandjani, Mostafa Farahbakhsh, Zahra Jahangiri, Shahriyar Ghanbarzadeh Javid, Hosein Azizi
Association Between Symptom Severity and Medication Adherence in Adults with Bipolar Disorder Reporting Adherence Challenges
Martha Sajatovic, Farren Briggs, Clara Adeniyi, Jacob Koopman, Jessica Black, Celeste Weise, Nicole Fiorelli, Joy Yala, Mohammad Lesanpezeshki, Douglas Einstadter, Jennifer B Levin
The Effectiveness and Safety of Stellate Ganglion Block in the Treatment of Symptoms from Long COVID-19: A Pilot Study
Alexa O Levey, Grant H Chen, Alexandra Ngyuen, Luis Ostrosky-Zeichner, Jamal Hasoon, Sepideh Saroukhani, Matthew Lin
Ultrasonically Determined Thyroid Volume in Individuals with Bipolar Disorder on Lithium Prophylaxis Compared with Healthy Controls
Anjali Bhasin, Devasenathipathy Kandasamy, Yashdeep Gupta, Raman Deep, Raka Jain
Metabolic Syndrome among Patients Taking Atypical Antipsychotics: A Comparative Cross-Sectional Study at Erada and Mental Health Complex in Taif, Saudi Arabia
Dhaifallah M Alhasani, Anas Ibn Auf, Ahmed A Alghamdi, Abdullah R Alzahrani
Long Acting Injectables and their Correlation with Subjectivity in Schizophrenia Spectrum Disorder
Ivano Caselli, Alessandra Gasparini, Marta Ielmini, Giulia Lucca, Stefano Amorosi, Nicola Poloni, Camilla Callegari
The Role of Religiosity and Guilt in Symptomatology and Outcome of Obsessive Compulsive Disorder
Kumar Rakesh, Sharma Arvind, Bansal Pir Dutt, Bahetra Mamta, Saini Bhavneesh, Moria Kavita, Kaur Navneet, Gupta Shrutika, Bansal Priyanka, Kumar Arun, Kaur Harkamal, Kaur Jagdeep
Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression
Jennifer R. Goldschmied, Arjun Sengupta, Anup Sharma, Lynne Taylor, Knashawn H. Morales, Michael E. Thase, Michael E. Thase, Aalim Weljie, Matthew S. Kayser
Obesogenic Medications and Weight Gain Over 24 Weeks in Patients with Depression: Results from the GUIDED Study
Jess G Fiedorowicz, Lisa Brown, James Li, Sagar V Parikh, Boadie W Dunlop, Brent P Forester, Richard C Shelton, Michael E Thase, Matthew Macaluso, Kunbo Yu, John F Greden
Selective Serotonin Reuptake Inhibitors and Nutraceutical Combination in Major Depression Disorder: A Case-Control Study
Marta Ielmini, Ivano Caselli, Francesca Ceccon, Marcello Diurni, Nicola Poloni, Camilla Callegari
A Comprehensive Monitoring of Clozapine and Related Components in Clinical Practices. Saudi Arabian Scenario
Jisha M Lucca, Fatima M Al-Turaifi, Al-Mubayedh Safyah, Feras A Hamad Al-Awad
Characteristics of Inpatients Prescribed Dopamine Receptor Blocking Agents
Shaina Schwartz, Lauren Dinkla, Jocelyn Pullen, Rachel Bernard, Archana Kumar
Demographic and Clinical Characteristics of Antipsychotic Drug-Treated Older Adults with Bipolar Disorder from the Global Aging & Geriatric Experiments in Bipolar Disorder Database (GAGE –BD)
Peijun Chen, Lisa T Eyler, Ariel Gildengers, Alexandra JM Beunders, Hilary P Blumberg, Farren BS Briggs, Annemiek Dols, Soham Rej, Orestes V Forlenza, Esther Jimenez, Benoit Mulsant, Sigfried Schouws, Melis Orhan, Kaylee Sarna, Ashley N Sutherland, Eduard Vieta, Shangying Tsai, Joy Yala, Luca M Villa, Martha Sajatovic
6 Weeks Monotherapy with Antipsychotic Drug Reduced Inflammatory Markers in Bipolar Disorder Patients
Marco Ferrari, Marco Godio, Camilla Callegari, Marco Cosentino, Franca Marino
Influence of CYP2C19*17 Genetic Polymorphism on the Steady-State Concentration of Escitalopram in Patients with Recurrent Depressive Disorder
MS Zastrozhin, VYu Skryabin, F Rwere, AE Petukhov, EP Pankratenko, SA Pozdniakov, VA Ivanchenko, VV Noskov, IA Zaytsev, NV Vinokurova, DS Horyaev, RV Vlasovskih, EA Bryun, DA Sychev
Lidocaine Ineffectiveness Suggests New Psychopharmacology Drug Target
Mark Mintz, Victor Badner, Lynn K. Feldman, Pnina Mintz, Mana Saraghi, Jonathan Diaz, Irina Mezhebovsky, Irene Axelrod, Joseph Gleeson, Chang Liu, Cathy Smith, Helen Chow, David Zurakowski, Michael M. Segal
Sleep Deprivation & Amphetamine Induced Psychosis
Amr Said Shalaby, Abdullah Osama Bahanan, Mishal Hasan Alshehri, Khaled Ahmed Elag
Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies
Bryan Dirks, Maurizio Fava, Sarah D Atkinson, Mark Joyce, Michael E Thase, Becky Howell, Tim Lin, Serge Stankovic
A Randomized, Double-Blind, Controlled Clinical Trial of Omega-3 Fatty Acids and Inositol as Monotherapies and in Combination for the Treatment of Pediatric Bipolar Spectrum Disorder in Children Age 5–12
Janet Wozniak, Abigail Farrell, Maura DiSalvo, Atilla Ceranoglu, Mai Uchida, Carrie Vaudreuil, Gagan Joshi, Stephen V Faraone, Emmaline Cook, Joseph Biederman
Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar Disorder
Charles L Bowden, Richard Priesmeyer, Mauricio Tohen, Vivek Singh, Joseph R Calabrese, Terry Ketter, Andrew Nierenberg, Michael E Thase, Gregg Siegel, Leslie H Siegel, Jim Mintz, Rif S El-Mallakh, Susan L McElroy, Melissa Martinez
ADHD and Drug Holidays: Effects on Anthropometric Changes during Methylpenidate Treatment
Serkan Turan, Çağatay Ermiş, Victor Pereira-Sanchez, Mustafa Tunctürk, Aynur Akay Pekcanlar
Sex Differences in Antipsychotic Related Metabolic Functioning in Schizophrenia Spectrum Disorders
The Addition of Amphetamine to Potentially Sedating Medication Regimens: An Exploratory Investigation of the Impact upon Reaction Time and Sustained Attention
Impact of a Student Pharmacist Driven Medication Reconciliation and Antidepressant Treatment History Project at a Depression Clinic: A Pilot Study
Stella S. Tang, Leanna Jaward, Kristen Ward, Sagar V. Parikh, Jolene R. Bostwick
Patient Response Trajectories in Major Depressive Disorder
Klaus G. Larsen, Sidney H. Kennedy, Elin Heldbo Reines, Michael E. Thase
Going Virtual During a Pandemic: An Academic Psychiatry Department’s Experience with Telepsychiatry
Sagar V Parikh, Danielle S Taubman, Mary Grambeau, Rena A Menke, Mary C Blazek, Jennifer Sullivan, Jennifer Severe, Paresh D Patel, Gregory W Dalack
Impact of the Omics-Based Biomarkers on the Fluvoxamine’s Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder
MS Zastrozhin, VYu Skryabin, VYu Smirnov, AK Zastrozhina, EV Kaverina, DA Klepikov, EA Grishina, KA Ryzhikova, IV Bure, EA Bryun, DA Sychev
Evaluation of Risk Factors Associated to Prescription of Benzodiazepines and its Patterns in a Cohort of Patients from Mental Health: A Real World Study in Spain
Jorge Simal-Aguado, María-Pilar Campos-Navarro, Francisco Valdivia-Muñoz, Alejandro Galindo-Tovar, Juan Antonio García-Carmona
A Phase 3 Placebo-Controlled Trial of Once-Daily 400-mg and 600-mg SPN-812
Azmi Nasser, Tesfaye Liranso, Toyin Adewole, Nicholas Fry, Joseph T. Hull, Fatima Chowdhry, Gregory D. Busse, Zare Melyan, Andrew J. Cutler, Robert L. Findling, Stefan Schwabe
Impact of the Omics-Based Biomarkers on the Mirtazapine’s Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder
MS Zastrozhin, VYu Skryabin, VYu Smirnov, AK Zastrozhina, EV Kaverina, DA Klepikov, EA Grishina, KA Ryzhikova, IV Bure, EA Bryun, DA Sychev
Clozapine Prolongs Cortical Silent Period in Patients with Treatment- Resistant Schizophrenia
Atsuhiro Miyazawa, Nobuhisa Kanahara, Yusuke Nakata, Satoshi Kodama, Hiroshi Kimura, Atsushi Kimura, Yasunori Oda, Hiroyuki Watanabe, Masaomi Iyo
Cocaine is a Major Risk Factor for Antipsychotic Induced Akathisia, Parkinsonism and Dyskinesia
The Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Hospitalized Patients with Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Study
Jean-Pierre Lindenmayer, David Brown, Sherry Liu, Martin Brecher, and Didier Meulien, on behalf of the Study 41 investigators
Efficacy of Print Advertising for a Bipolar Disorder Study
Timothy Petersen, PhD, Roy H. Perlis, MD, Chris Ticknor, MD, Jim Lohr, MD, H. Brent Solvason, MD, PhD, John P. O’Reardon, MD, Madelaine M. Wohlreich, MD, Charissa Andreotti, BSc, Michael Wilson, MS, and Maurizio Fava, MD
A Randomized, Placebo-Controlled Pilot Study of Quetiapine-XR Monotherapy or Adjunctive Therapy to Antidepressant in Acute Major Depressive Disorder with Current Generalized Anxiety Disorder
Ranran Li, Renrong Wu, Jun Chen, David E. Kemp, Ming Ren, Carla Conroy, Philip Chan, Mary Beth Serrano, Stephen J. Ganocy, Joseph R. Calabrese, Keming Gao
Sexual Pain among Malaysian Women Receiving Antidepressant: A Comparison between Escitalopram and Fluoxetine
Hatta Sidi, Duni Asmidar, Loh Huai Seng, Nik Ruzyanei Nik Jaafar, Marhani Midi, Ng Chong Guan
An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder
Patricia Pilkinton, Carlos Berry, Seth Norrholm, Al Bartolucci, Badari Birur, Lori L. Davis
Statistical Strategies for Randomized Controlled Clinical Trials to Detect Differential Onset of Action
Clinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data
Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)
Prakash S. Masand, MD, James Eudicone, MS, Andrei Pikalov, MD, PhD, Robert D. McQuade, PhD, Ronald N. Marcus, MD, Estelle Vester-Blokland, MD, and Berit X. Carlson, PhD
Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice
Alisa B. Busch, MD, MS, Richard G. Frank, PhD, and Gary Sachs, MD
Addressing Methodological Issues in Studying Antidepressant Onset Efficacy Using Prespecified Sensitivity Analyses
Ilya Lipkovich, PhD, Craig H. Mallinckrodt, PhD, Apurva Prakash, BA, and Andrew A. Nierenberg, MD
Predictors of Non-Stabilization during the Combination Therapy of Lithium and Divalproex in Rapid Cycling Bipolar Disorder: A Post-hoc Analysis of Two Studies
Keming Gao, David E. Kemp, Zuowei Wang, Stephen J. Ganocy, Carla Conroy, Marry Beth Serrano, Martha Sajatovic, Robert L. Findling, Joseph R. Calabrese
The Effectiveness of Long-Acting Injectable Risperidone in a Population of Psychiatric Out-Patients: 1-Year Naturalistic Study
Switching from Other Agents to Extended-Release Carbamazepine in Acute Mania
Alexander Bystritsky, MD, Lauren Kerwin, BA, Jamie D. Feusner, MD, and Tanya Vapnik, PhD
Financial Incentives to Improve Adherence to Medication in Five Patients with Schizophrenia in The Netherlands
Predictive Value of Early Improvement in Bipolar Depression Trials: A Post-hoc Pooled Analysis of Two 8-week Aripiprazole Studies
D.E. Kemp, J.R. Calabrese, J.M. Eudicone, S. Ganocy, Q.V. Tran, R.D. McQuade, R.N. Marcus, E. Vester-Blokland, R. Owen, B.X. Carlson
Patient Outcomes With Education, Drug Therapy, and Support: A Study of Venlafaxine ER-Treated Outpatients with Major Depressive Disorder
Kasia Lobello, Sujana Reddy, Jeff Musgnung, Ronald Pedersen, Philip T. Ninan
Treatment of Pathological Gambling with Naltrexone Pharmacotherapy and Brief Intervention: A Pilot Study
Tuuli Lahti, Jukka T. Halme, Maiju Pankakoski, David Sinclair, Hannu Alho
The Sex Effects Scale: Pilot Validation in a Healthy Population
Sidney H. Kennedy, Sakina J. Rizvi, Kari Fulton, Janet Ellis, Lena C. Quilty, Lakshmi Ravindran
Duloxetine in Military Posttraumatic Stress Disorder
Gerardo Villarreal, José M. Cañive, Lawrence A. Calais, Gregory Toney, Ashley K. Smith
Metabolic Syndrome with Different Antipsychotics: A Multicentre Cross-Sectional Study
Cem Cerit, Meltem Vural, Şükriye Boşgelmez, Eylem Özten, Ahmet Tamer Aker, Mustafa Yıldız
Lamotrigine Adjunctive Therapy to Lithium and Divalproex in Depressed Patients with Rapid Cycling Bipolar Disorder and a Recent Substance Use Disorder: A 12-week, Double-Blind, Placebo-Controlled Pilot Study
Zuowei Wang, Keming Gao, David E. Kemp, Philip K. Chan, Mary Beth Serrano, Carla Conroy, Yiru Fang, Stephen J. Ganocy, Robert L. Findling, Joseph R. Calabrese
A Placebo-Controlled Trial of Guanfacine for the Treatment of Post Traumatic Stress Disorder in Veterans
Lori Davis, MD, L. Charles Ward, PhD, Ann Rasmusson, MD, Jason M. Newell, LCSW, PIP, Elizabeth Frazier, MS, and Steven M. Southwick, MD
Treatment of Children with Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Multicenter, Double-Blind, Crossover Study of Extended-Release Dexmethylphenidate and D,L-Methylphenidate and Placebo in a Laboratory Classroom Setting
Raul Silva, MD, Rafael Muniz, MD, Kevin McCague, MA, Ann Childress, MD, Matthew Brams, MD, and Alice Mao, MD
Efficacy of Duloxetine for the Treatment of Depression: Relationship to Most Recent Antidepressant Trial
Timothy Petersen, PhD, Roy H. Perlis, MD, Chris Ticknor, MD, Jim Lohr, MD, H. Brent Solvason, MD, PhD, John P. O’Reardon, MD, Madelaine M. Wohlreich, MD, Charissa Andreotti, BSc, Michael Wilson, MS, and Maurizio Fava, MD
A Pilot Study of the Pharmacodynamic Impact of SSRI Drug Selection and Beta-1 Receptor Genotype (ADRB1) on Cardiac Vital Signs in Depressed Patients: A Novel Pharmacogenetic Approach
Kelan L.H. Thomas, Vicki L. Ellingrod, Jeffrey R. Bishop, Michael J. Keiser
A Pilot Controlled Trial of Bupropion XL Versus Escitalopram in Generalized Anxiety Disorder
By Alexander Bystritsky, MD, Lauren Kerwin, BA, Jamie D. Feusner, MD, and Tanya Vapnik, PhD
The Effect of a Novel Dietary Intervention on Weight Loss in Psychotropic Drug-Induced Obesity
Judith J. Wurtman, PhD, Janine M. McDermott, MA, Philip Levendusky, PhD, Karen Duca, PhD, and Richard Wurtman, MD
Candidate Gene Studies in Eating Disorders
Federica Tozzi, MD, Andrew W. Bergen, PhD, and Cynthia M. Bulik, PhD
Treatment Characteristics and Illness Burden Among European Americans, African Americans, and Latinos in the First 2,000 Patients of the Systematic Treatment Enhancement Program for Bipolar Disorder
Jodi M. Gonzalez, PhD, Peter Thompson, MD, Michael Escamilla, MD, Mako Araga, MS, Vivek Singh, MD, Niamh Farrelly, MD, Michael E. Thase, MD, David J. Miklowitz, PhD, and Charles L. Bowden, MD
Effect of Mirtazapine Orally Disintegrating Tablets on Health-Related Quality of Life in Elderly Depressed Patients with Comorbid Medical Disorders: A Pilot Study
Indira Varia, MD, Srimathi Venkataraman, MBBS, Caroline Hellegers, MA, Kenneth Gersing, MD, and P. Murali Doraiswamy, MD
Leptin and Leptin Receptor Gene Polymorphisms and Increases in Body Mass Index (BMI) from Olanzapine Treatment in Persons with Schizophrenia
Vicki L. Ellingrod, PharmD, BCPP, Jeffrey R. Bishop, PharmD, MS, Jessica Moline, BS, Ying-Chi Lin, MS, and Del D. Miller, PharmD, MD
Citalopram Versus Amitriptyline in Elderly Depressed Patients with or without Mild Cognitive Dysfunction: A Danish Multicentre Trial in General Practice
Claus Rosenberg, MD, Lise Lauritzen, MD, Jørgen Brix, MD, Jørgen B. Jørgensen, MD, Palle Kofod, MD, and Liselotte Been Bayer
Atypical Antipsychotics and Pituitary Neoplasms in the WHO Database
P. Murali Doraiswamy, MD, Gisela Schott, MD, MPH, Kristina Star, RN, Ralph Edwards, MD, and Bruno Mueller-Oerlinghausen, MD
Suicide Risk Analysis Among Patients Assigned to Psychotropics and Placebo
Arif Khan, MD, Russell L. Kolts, PhD, Amy E. Brodhead, MS, K. Ranga Krishnan, MD, and Walter A. Brown, MD
A Randomized Controlled Trial of Paroxetine for Noncardiac Chest Pain
P. Murali Doraiswamy, MD, Indira Varia, MD, Caroline Hellegers, MA, H. Ryan Wagner, PhD, Greg L. Clary, MD, John L. Beyer, MD, L. Kristin Newby, MD, John F. O’Connor, MD, Katherine L. Beebe, PhD, Christopher O’Connor, MD, and K. Ranga R. Krishnan, MD
Reliability and Validity of the Yale-Brown Obsessive-Compulsive Scale in Schizophrenia Patients
Lieuwe de Haan, MD, PhD, Britt Hoogeboom, MD, Nico Beuk, MD, Luuk Wouters, Peter M.A.J. Dingemans, PhD, and Don H. Linszen, MD, PhD
Brief Report: Paroxetine in Younger and Adult Individuals at High Risk for Suicide
Mark S. Bauer, MD, Stephen R. Wisniewski, PhD, Jane N. Kogan, PhD, Lauren B. Marangell, MD, Michael E. Thase, MD, Gary Sachs, MD, for the STEP-BD Investigators
Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Post Traumatic Stress Disorder: An Open Trial
Gerardo Villarreal, MD, Lawrence A. Calais, RN, CCRC, Jose M. Cañive MD, S. Laura Lundy, BS, Jacob Pickard, MA, and Gregory Toney, PharmD
Awareness of Metabolic Concerns and Perceived Impact of Pharmacotherapy in Patients with Bipolar Disorder: A Survey of 500 US Psychiatrists
Trisha Suppes, MD, PhD, Susan L. McElroy, MD, and Robert Hirschfeld, MD
Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
Larry Alphs, MD, PhD, John Panagides, PhD, and Scott Lancaster, MS
Donepezil for Cognitive Decline Following Coronary Artery Bypass Surgery: A Pilot Randomized Controlled Trial
P. Murali Doraiswamy, MD, Michael A. Babyak, PhD, Therese Hennig, PA-C, Ranak Trivedi, PhD, William D. White, MPH, Joseph P. Mathew, MD, Mark F. Newman, MD, and James A. Blumenthal, PhD
The Speed of Onset of Action of Alprazolam-XR Compared to Alprazolam-CT in Panic Disorder
David V. Sheehan, MD, MBA, Kathy Harnett Sheehan, PhD, and B.A. Raj, MD
Positron Tomographic Emission Study of Olfactory Induced Emotional Recall in Veterans with and without Combat-Related Post Traumatic Stress Disorder
Eric Vermetten, MD, PhD, Christian Schmahl, MD, Steven M. Southwick, MD, and J. Douglas Bremner, MD
Analysis of Symptoms in Patients With Major Depressive Disorder Treated With Desvenlafaxine or Placebo
Susan G. Kornstein, Maurizio Fava, Qin Jiang, Karen A. Tourian
Atypical Antipsychotic Drugs and Diabetes Mellitus in the US Food and Drug Administration Adverse Event Database: A Systematic Bayesian Signal Detection Analysis
Ross A. Baker, Andrei Pikalov, Quynh-Van Tran, Tatyana Kremenets, Ramin B. Arani, P. Murali Doraiswamy
Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing
Alisa B. Busch, Richard G. Frank, Gary Sachs, Sharon-Lise T. Normand
Neuropsychological Functioning in Patients with Post Traumatic Stress Disorder Following Short Term Paroxetine Treatment
Negar Fani, Noriyuki Kitayama, Ali Ashraf, Lai Reed, Nadeem Afzal, Farhan Jawed, J. Douglas Bremner
An Open-Label Assessment of Aripiprazole in the Treatment of PTSD
Sophie Robert, Mark B. Hamner, Valerie L. Durkalski, Mary W. Brown, Helen G. Ulmer
Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs. Generalized Anxiety Disorder: An Open-Label Trial
Jamie D. Feusner, Lauren Kerwin, Sanjaya Saxena, Alexander Bystritsky
REVAMP – Research Evaluating the Value of Augmenting Medication with Psychotherapy: Rationale and Design
Madhukar H. Trivedi, James H. Kocsis, Michael E. Thase, David W. Morris, Stephen R. Wisniewski, Andrew C. Leon, Alan J. Gelenberg, Daniel N. Klein, George Niederehe, Alan F. Schatzberg, Philip T. Ninan, Martin B. Keller
Frequency of Stimulant Treatment and of Stimulant-Associated Mania/Hypomania in Bipolar Disorder Patients
Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening
Robert MA Hirschfeld, MD, Joseph R. Calabrese, MD, Mark A. Frye, MD, Philip W. Lavori, PhD, Gary Sachs, MD, Michael E. Thase, MD, and Karen Dineen Wagner, MD, PhD
Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
Donald S. Robinson, MD, Michelle L. Gilmor, PhD, Ying Yang, PhD, George Moonsammy, PhD, Albert J. Azzaro, PhD, Dan A. Oren, MD, and Bryan J. Campbell, PharmD
Zonisamide for Bipolar Disorder, Mania or Mixed States: A Randomized, Double Blind, Placebo-Controlled Adjunctive Trial
Deborah Dauphinais, Michael Knable, Joshua Rosenthal, Mark Polanski, Norman Rosenthal
Rater Training for a Multi-Site, International Clinical Trial:What Mood Symptoms may be most Difficult to Rate?
Martha Sajatovic, Richa Gaur, Curtis Tatsuoka, Susan De Santi, Nathan Lee, Judith Laredo, Sulabh Tripathi
The Safety and Tolerability Profile of Vilazodone, A Novel Antidepressant for the Treatment of Major Depressive Disorder
Michael Liebowitz, Harry A. Croft, Daniel K. Kajdasz, Heidi Whalen, Susan Gallipoli, Maria Athanasiou, Carol R. Reed
The Efficacy and Tolerability of Once-daily Controlled-release Trazodone for Depressed Mood, Anxiety, Insomnia, and Suicidality in Major Depressive Disorder
David V. Sheehan, Anna Rozova, E. Roderich Gossen, Michael Gibertini
Early Predictors of Weight Gain Risk During Treatment with Olanzapine:Analysis of Pooled Data from 58 Clinical Trials
Ilya Lipkovich, Jennie G. Jacobson, Cathy Caldwell, Vicki Poole Hoffmann, Ludmila Kryzhanovskaya, Charles M. Beasley
Assessing Rates and Predictors of Tachyphylaxis During the Prevention of Recurrent Episodes of Depression With Venlafaxine ER for Two Years (PREVENT) Study
Anthony J. Rothschild, Boadie W. Dunlop, David L. Dunner, Edward S. Friedman, Alan Gelenberg, Peter Holland, James H. Kocsis, Susan G. Kornstein, Richard Shelton, Madhukar H. Trivedi, John M. Zajecka, Corey Goldstein, Michael E. Thase, Ron Pedersen, Martin B. Keller
Agomelatine for Depression in Schizophrenia: A Case-Series
Jochen Mutschler, Nicolas Rüsch, Herdis Schönfelder, Uwe Herwig, Annette B. Brühl, Martin Grosshans, Wulf Rössler, Heike Russmann
Extended Release Quetiapine Fumarate (Quetiapine XR) as Adjunct Therapy in Patients with Generalized Anxiety Disorder and a History of Inadequate Treatment Response: A Randomized, Double-Blind Study
Arifulla Khan, Sarah Atkinson, Irina Mezhebovsky, Fahua She, Todd Leathers, Sanjeev Pathak
Ramelteon for Insomnia Related to Attention-Deficit/Hyperactivity Disorder (ADHD)
Rachel E. Fargason, Karen Gamble, Kristin T. Avis, Rachel C. Besing, Cherry W. Jackson, Marshall E. Cates, Roberta May
Efficacy and Safety of Paliperidone Extended Release 1.5 mg/day—A Double-blind, Placebo- and Active-Controlled, Study in the Treatment of Patients with Schizophrenia
Danielle Coppola, Rama Melkote, Caroline Lannie, Jaskaran Singh, Isaac Nuamah, Srihari Gopal, David Hough, Joseph Palumbo
Zonisamide for Bipolar Depression: A Randomized, Double Blind, Placebo-Controlled, Adjunctive Trial
Deborah Dauphinais, Michael Knable, Joshua Rosenthal, Mark Polanski, Norman Rosenthal